No Detail Found!

Development of Written Counseling Tool for Subcutaneous Anticoagulant Use in COVID-19 Patients

Author(s)
LeeFern Low Faculty of Pharmacy, University Kebangsaan Malaysia, Jalan Raja Muda Abdul Aziz, 50300, Kuala Lumpur, Malaysia; Department of Pharmacy, Hospital Sultanah Aminah Johor Bahru, Persiaran Abu Bakar Sultan, 80100 Johor Bahru, Johor, Malaysia.
Farida Islahudin Faculty of Pharmacy, University Kebangsaan Malaysia, Jalan Raja Muda Abdul Aziz, 50300, Kuala Lumpur, Malaysia.
Shamin Mohd Saffian Faculty of Pharmacy, University Kebangsaan Malaysia, Jalan Raja Muda Abdul Aziz, 50300, Kuala Lumpur, Malaysia
Abstract
There is a lack of subcutaneous anticoagulant counseling tools for COVID-19 patients. This study aims to develop and validate a written counseling tool for subcutaneous anticoagulant use in COVID-19 patients. A prospective cohort study was performed with expert panels and patients. The tool was validated by hospital pharmacists using Content Validity Index (I-CVI), Scale-level-CVI (S-CVI), and Universal Acceptance (UA). Face validation by patients was determined using Item Acceptance Index (IAI), and Universal Acceptance (UA). Hospital pharmacists (n=26) were mostly female (n=18, 69.2%) and Chinese (n=20, 76.9%), with a mean age of 35.8±2.9 years. All items were assessed relevantly (n=18, 100%), I-CVIs ranging from 0.96-1.00 by hospital pharmacists. The average proportion of items, I-CVI average, (Sum of I-CVI/no. of items: 17.88/18) was reported as 0.99. S-CVI/UA (Sum of UA/no. of items: 15/18) was reported as 0.83, and SCVI/Average (Sum of I-CVI/no. of items: 17.88/18) was reported as 0.99 indicating high content validity. Patients (n=28) involved in face validation of the construct were mostly female (n=19, 67.9%), Malay (n=46.4%), and tertiary educated (n=20, 71.4%) with a mean age of 38.0±9.8 years. All items were marked as relevant (n=18, 100%), with IAI ranging from 0.93-1.00, suggesting patients accepted each item of the construct. The average proportion of items was reported as 0.99 (Sum of IAI/no. of items: 17.82/18), indicating excellent acceptance and content comprehension among patients. The developed counseling tool is acceptable for anticoagulant education among COVID-19 patients.
Publication Details
Page(s) 19-24
Published Journal: Archives of Pharmacy Practice, Volume: 14, Issue: 2, Year: 2023

Request the full text from PASTIC

Keywords
COVID-19 patients, Validation, Anticoagulants, Counseling tool, Medication education
0

Citations

0

Downloads

72

Views